Ayala Pharmaceuticals Inc (ADXS)

[mm2k]

I understand all of that, but the bottom line is that the market sees much more value in anything that is a cancer cure. And in reality, patients and insurance companies are much more likely to pay big dollars for anything that is a potential cure vs. something that increases the likelihood of surviving 6 months. Don't get me wrong, there is significant value in extending life by 6 months, but it's easy to understand why the KITE treatment is considered much more valuable.